David O'Malley

David O'Malley, MD


Make an Appointment

Overall Patient Satisfaction Rating

4.9 out of 5




I am a professor in the Department of Obstetrics and Gynecology at The Ohio State University College of Medicine and the director of the Division of Gynecologic Oncology at the OSUCCC – James, where I've been a faculty member since 2005. I completed my gynecologic oncology fellowship at Yale University, residency at Case Western Reserve University (MetroHealth) and the Cleveland Clinic Foundation, medical school at Wayne State and earned my undergraduate degree at the University of Notre Dame.

I am the director for clinical research in gynecologic oncology, as well as the co-director of the gynecologic oncology phase I program, and I also serve as the ORIEN physician liaison for the Ohio State University Comprehensive Cancer Center. I am active nationally as a committee member for the NCI Gynecologic Cancer Steering Committee’s Ovarian Task Force, NRG Oncology (Ovarian Cancer and Developmental Therapeutics Groups), Society of Gynecologist Oncology and the American Society of Clinical Oncology. My passion for improving the care of patients with gynecologic cancers and expertise in ovarian cancer resulted in my appointment to the panel of the National Comprehensive Cancer Network (NCCN) Guidelines for Ovarian Cancer, where I continue as an active participant.

My drive to have no patient with a gynecologic cancer succumb to their disease guides my research that specializes in the development of therapeutics/treatments for gynecologic cancers, concentrating on ovarian and uterine (endometrial). I have designed, coordinated and published on all levels of clinical trials to include phase I, II and III studies with a special interest in novel compounds. I continue to work to improve not only the therapies (novel techniques/targets/immune therapy) but to identify patients who would benefit (or not benefit) from different treatment options in ovarian and uterine cancer (specifically high-risk histologies) while minimizing side effects.

The quest to improve patient outcomes has led me to my work on improving surgical techniques. Robotic-assisted, minimally invasive surgical techniques have been implemented in all aspects of practice, resulting in the publication of the improved outcomes and as an instructor on these techniques at a national level.

I am honored and humbled to help care for the amazing women who are my patients and their families. Improving the care of women with gynecologic cancer through research has led to me being recognized with over 100 publications in the most respected journals, including New England Journal of Medicine, Journal of Clinical Oncology, Lancet Oncology, JAMA Oncology and Nature Genetics. My compassionate nature and communication has been recognized with patient satisfaction that ranks at the very top for the country. My accomplishments have also resulted in being named as one of the Best/Top Doctors in America by U.S. News and World Report (Castle Connelly) and Best Doctors for multiple years. However, my greatest pride comes from my family, including my beautiful wife and our five amazing children.

Education and Background


Wayne State University School of Medicine

Detroit, MI


Case Western Reserve University

Cleveland, OH


OB/GYN / Gynecological Oncology

Yale University School of Medicine

New Haven, CT

Board Certifications

American Board of OB/GYN

American Board of OB/GYN (Subspecialty: Gynecologic Oncology)

Academic Department

Department of Obstetrics & Gynecology

Division of Gynecologic Oncology

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 12/20/2018, Dr. O'Malley has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.


Clovis Oncology


Tesaro, Inc.

Regeneron Pharmaceuticals

Janssen Research


AbbVie Inc.

Ambry Genetics

Immunogen, Inc.

Myriad Genetic Laboratories, Inc.



Patient Satisfaction Review

The overall patient satisfaction rating is an average of all patient responses to the five questions gathered from the Outpatient Oncology survey, developed by Press Ganey Associates for use in oncology clinics across the country. On behalf of The James, Press Ganey administers the survey to patients who see our providers in an outpatient clinic office. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page

The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of The James.

Overall Ratings (out of 232 reviews)
4.9 out of 5
Kept you informed about your condition and treatment

4.9/ 5

Amount of time spent with you

4.9/ 5

Concern for your questions and issues

4.9/ 5

Skill and knowledge

4.9/ 5

Overall quality of care

4.9/ 5

Patient Comments (9 total comments)

Reviewed: 5/13/2019

My doctor is very good. I have great confidence in him.

Reviewed: 4/29/2019

Very kind courteous respectful and clear explanations.

Reviewed: 4/8/2019

Dr. O'Malley is knowledgeable, friendly, and respects patients.

Reviewed: 3/25/2019

I could not have chosen a a more compassionate doctor. I am thrilled with the kindness and empathy with which Dr. O'Malley has treated me. He has made me feel like I am in excellent hands since my first impression of him, and gone to great lengths researching and working up my extraordarily rare diagnosis. I will be forever grateful to him and his team for my care.

Reviewed: 3/9/2019

excellenmt care from dr omalley--he cares!

Reviewed: 2/18/2019

Dr. O'Malley and Dr. Cosgrave are both very thorough and they spent a good amount of time asking & answering questions.

Reviewed: 2/18/2019

takes his time with me and answered all my questions

Reviewed: 2/8/2019

Dr. O'Malley is patients, professional - a wonderful physician.

Reviewed: 2/4/2019

Takes time to answer your questions.


Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine.

Matulonis UA, Birrer MJ, O'Malley DM, Moore KN, Konner J, Gilbert L, Martin LP, Bauer TM, Oza AM, Malek K, Pinkas J, Kim SK

Clin Cancer Res 25


A Rare Case of Atypical Placental Site Nodule With an Emerging Intermediate Trophoblastic Tumor.

Dholakia J, Chen W, O'Malley DM, Ronnett BM

Int J Gynecol Pathol in press


Clinical Trials | Lead




Related Videos

Clinical Trial Uses Tumor Cells to Treat Cervical Cancer Patients
New Study Offers Fertility-Sparing Option for Cervical Cancer Patients
Why Choose a Comprehensive Cancer Center - The James
Back to Find a Doctor Search

Make an Appointment


Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator


Please enter a keyword (i.e. Name, Location) or choose a Cancer Type